Anti-tumor Effect in Vitro of ~(188)re Labeled Herceptin-coated Magnetite Nanoparticles

李贵平,汪勇先,张一帆,张春富
DOI: https://doi.org/10.3760/cma.j.issn.2095-2848.2007.01.006
2007-01-01
Abstract:Objective SKBR-3 is a breast carcinoma cell line that has overexpression of HER-2/neu proto-oncogen.The aim of this study was to investigate the inhibitive effects of inununo-magnetite targeting thera- py ~(188)Re-Herceptin-coated magnetite nanoparticles(MNP)in SKBR-3 in the presence of magnetic field.Meth- ods The Heceptin-MNP and Herceptin were radiolabeled with ~(188)Re by a direct labelling method,and the histi- dine-MNP was radiolabeled with ~(188)Re(~(188)Re-MNP)by means of fac-[~(188)Re(CO)_3(H_2O)_3]~+as a precursor.By applying a directional external magnetic field with 0.5 T across a 96-well plate containing SKBR-3 cells,the cells were incubated respectively,with ~(188)Re-Herceptin-MNP,~(188)Re-Herceptin,~(188)Re-MNP and ~(188)ReO_4~- with different radioactivity dose(3.7×10~4,18.5×10~4,37×10~4,55.5×10~4 and 74×10~4 Bq/ml).The inhibition was determined with 3-[4,5-dimethythiazol-2-yl]-2,5-diphenyhe-trazolium bromide(MTT)col- orimetric assay.Results The 50% inhibition doses(IC_(50))of~(188)Re-Herceptin-MNP,~(188)Re-Herceptin, ~(188)Re-MNP and ~(188)ReO_4~-were 53.1×10~4,76.1×10~4,169×10~4 and 175 R 10~4 Bq/L.Conclusion Though both ~(188)Re-Herceptin-MNP and ~(188)Re-Herceptin can effectively inhibit the growth of tumor cells, ~(188)Re-Herceptin-MNP seems to be more suitable for immuno-magnetite targeting therapy in HER-2/neu posi- tive breast cancer patients in the future.
What problem does this paper attempt to address?